T1 mapping in myocarditis – headway to a new era for cardiovascular magnetic resonance

References

• Caforio AL, Pankuweit S, Arbustini E, et al. European society of cardiology working group on myocardial and pericardial diseases. current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the european society of cardiology working group on myocardial and pericardial diseases. Eur Heart J 2013;34:2636-48
   PubMed Web of Science ®Google Scholar
• Kindermann I, Barth C, Mahfoud F, et al. Update on myocarditis. J Am Coll Cardiol 2012;59:779-92
   PubMed Web of Science ®Google Scholar
• Cooper LT, Baughman KL, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the american heart association, the american college of cardiology, and the european society of cardiology endorsed by the heart failure society of america and the heart failure association of the european society of cardiology. Eur Heart J 2007;28:3076-93
   PubMed Web of Science ®Google Scholar
• Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004;109:1250-8
   PubMed Web of Science ®Google Scholar
• Lurz P, Eitel I, Adam J, et al. Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis. JACC Cardiovasc Imaging 2012;5(5):513-24
   PubMed Web of Science ®Google Scholar
• Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol 2009;53(17):1475-87
   PubMed Web of Science ®Google Scholar
• Chu GW, Flewitt J, Mikami Y, et al. Assessment of acute myocarditis by cardiovascular MR: diagnostic performance of shortened protocols. Int J Cardiovasc Imaging 2013;29:1077-83
   PubMed Web of Science ®Google Scholar
• Grün S, Schumm J, Greulich S, et al. Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. J Am Coll Cardiol 2012;59:1604-15
   PubMed Web of Science ®Google Scholar
• Francone M, Chimenti C, Galea N, et al. CMR sensitivity varies with clinical presentation and extent of cell necrosis in biopsy-proven acute myocarditis. JACC Cardiovasc Imaging 2014;7:254-63
   PubMed Web of Science ®Google Scholar
• Rehwald WG, Fieno DS, Chen EL, et al. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 2002;105(2):224-9
   PubMed Web of Science ®Google Scholar
• Coelho-Filho OR, Mongeon FP, Mitchell R, et al. Role of transcytolemmal water-exchange in magnetic resonance measurements of diffuse myocardial fibrosis in hypertensive heart disease. Circ Cardiovasc Imaging 2013;6(1):134-41
   PubMed Web of Science ®Google Scholar
• Puntmann VO, Voigt T, Chen Z, et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging 2013;6(4):475-84
   PubMed Web of Science ®Google Scholar
• Puntmann VO, Taylor PC, Barr A, et al. Towards understanding the phenotypes of myocardial involvement in the presence of self-limiting and sustained systemic inflammation: a magnetic resonance imaging study. Rheumatology (Oxford) 2010;49:528-35
   PubMed Web of Science ®Google Scholar
• Puntmann VO, D’Cruz D, Smith Z, et al. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Circ Cardiovasc Imaging 2013;6(2):295-01
   PubMed Web of Science ®Google Scholar
• Hinojar R, Foote L, Arroyo Ucar E, et al. Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR. JACC Cardiovasc Imaging 2015;8(1):37-46
   PubMed Web of Science ®Google Scholar
• Ferreira VM, Piechnik SK, Dall’Armellina E, et al. T1 mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. JACC Cardiovasc Imaging 2013;6(10):1048-58
   PubMed Web of Science ®Google Scholar
• Dall’Armellina E, Ferreira VM, Kharbanda RK, et al. Diagnostic value of pre-contrast T1 mapping in acute and chronic myocardial infarction. JACC Cardiovasc Imaging 2013;6(6):739-42
   Google Scholar
• Dabir D, Child N, Kalra A, et al. Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 2014;16:69
   Google Scholar
• Friedrich MG. Myocardial T1: the rise of a novel biomarker continues. JACC Cardiovasc Imaging 2015;8(1):47-9
   Google Scholar
• Kramer CM, Chandrashekhar Y, Narula J. Is it T1me for tissue characterization in myocarditis? JACC Cardiovasc Imaging 2015;8(1):115-17
   Google Scholar
• Radunski UK, Lund GK, Stehning C, et al. CMR in patients with severe myocarditis: diagnostic value of quantitative tissue markers including extracellular volume imaging. JACC Cardiovasc Imaging 2014;7(7):667-75
   Google Scholar
• Luetkens JA, Doerner J, Thomas DK, et al. Acute myocarditis: multiparametric cardiac MR imaging. Radiology 2014;273(2):383-92
   Google Scholar
• Hinojar R, Foote L, Arroyo Ucar E, et al. Myocardial T2 mapping for improved detection of inflammatory myocardial involvement in acute and chronic myocarditis. J Cardiovas Magnet Res 2014;16(Suppl 1):O63
   PubMedGoogle Scholar
• Puntmann VO, Foote L, Hinojar R, et al. 130 reproducibility of T1 and T2 mapping in health and disease, and assessment of T2 variability across the normal myocardium. Heart 2014;100(Suppl 3):A76
   Google Scholar
• Thavendiranathan P, Walls M, Giri S, et al. Improved detection of myocardial involvement in acute inflammatory cardiomyopathies using T2 mapping. Circ Cardiovasc Imaging 2012;5(1):102-10
   PubMed Web of Science ®Google Scholar
• Ugander M, Bagi PS, Oki AJ, et al. Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction. JACC Cardiovasc Imaging 2012;5(6):596-603
   PubMed Web of Science ®Google Scholar
• Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 2009;30:1995-02
   PubMed Web of Science ®Google Scholar
• Felix SB, Staudt A, Dorffel WV, et al. Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three month results from a randomized trial. J Am Coll Cardiol 2000;35:1590-8
   PubMed Web of Science ®Google Scholar